To investigate the effect of beta-catenin on PrKD1 gene regulation, we performed CHIP assays using high PrKD1 expressing LNCaP prostate cancer cell lysate and beta-catenin antibody. The gene discussed is CTNNB1; the disease is prostate carcinoma.